Compare BRCC & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRCC | ANTX |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.1M | 158.8M |
| IPO Year | 2022 | 2022 |
| Metric | BRCC | ANTX |
|---|---|---|
| Price | $1.16 | $4.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $2.25 | $2.00 |
| AVG Volume (30 Days) | ★ 728.0K | 442.7K |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.56 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $398,263,000.00 | N/A |
| Revenue This Year | $9.68 | N/A |
| Revenue Next Year | $9.59 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.73 | N/A |
| 52 Week Low | $0.60 | $1.00 |
| 52 Week High | $2.10 | $6.91 |
| Indicator | BRCC | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 51.60 |
| Support Level | $1.18 | $3.91 |
| Resistance Level | $1.20 | $5.13 |
| Average True Range (ATR) | 0.08 | 0.35 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 58.70 | 51.28 |
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.